June 2023

New polymeric heart valve implanted for first time | AI model for heart attack assessments impresses ()
A new Class I recall | The first type 1 diabetes treatment of its kind | VR during TAVR | More from the last week ()
FDA approves first cellular therapy for type 1 diabetes | Cardiologists say EPA proposal could put patients at risk ()
News Alert: FDA approves first cellular therapy to treat type 1 diabetes ()
Economics Highlights: Doc agrees to pay $5M | A new class-action lawsuit | Colchicine for CVD: What will it cost? ()
Balloon-expandable vs. self-expandable TAVR valves | Cardiologist the highest-paying job in 2 states | IVL for TLE ()
What will Lodoco cost? Looking ahead after FDA’s colchicine approval | A new catheter recall | Cyberattack leads to lawsuit ()
News Alert: FDA announces new recall of interventional devices due to risk of catheter separation ()
Care Delivery Highlights: Top 20 children’s hospitals for cardiology | Surgeon racks up 21 malpractice settlements ()
VR during TAVR | Cardiologists applaud FDA’s colchicine approval | Abbott awards $2.6M to ADA ()
Cardiology at the supermarket: Shopping carts upgraded to detect AFib | Imaging companies join forces ()
FDA approves colchicine for CVD | Top 20 children’s hospitals | Heart damage after TAVR | More from the last week ()
Heart Rhythm Highlights: FDA says iRhythm committed multiple violations | Left bundle branch pacing | More ()
FDA panel to review renal denervation data | Shared decision-making | PE-backed cardiology group inks another deal ()
Top 20 children’s hospitals for cardiology | ASE 2023 | FDA grants AI model its breakthrough device designation ()
News Alert: The top 20 children’s hospitals for cardiology and heart surgery ()
History made: The first anti-inflammatory drug for CVD | FDA approves DCB, leading to $27M payment from Abbott ()
News Alert: FDA approves first anti-inflammatory drug for treating cardiovascular disease ()
Cardiac Imaging Highlights: Managing patients with SCAD | Heart damage after TAVR | Cardiology groups unite ()
Cardiac damage after TAVR | Cardiologist's suicide prompts coroner to share concerns ()
Heart patients suffering from PTSD | FDA clears new ablation catheter | Cardiology group hit by cyberattack ()
The first TAVR of its kind | A new recall | Heart surgeon racks up 21 malpractice settlements | More from the last week ()
Heart Health: Marijuana & PAD | WHO warns against use of artificial sweeteners | Plant-based diets | More ()
Cardiologist agrees to pay $5M | Key advances in STEMI care, drug delivery | Severe TR in high-risk HF patients ()
FDA clears new device for blood clot removal | How a heart surgeon racked up 21 malpractice settlements | Mitral valve repair ()
Interventional Cardiology Highlights: FDA clears new guidewire | Innovation in the cath lab | Managing SCAD ()
Rethinking SAVR in the TAVR era | Severe heart condition reverses in 3 patients, shocking experts ()
FDA's warning about recalled devices | A historic TAVR | Cardiologist could face life in prison for sexual assault ()
Vascular & Endovascular: Antithrombotic therapy after TAVR | Marijuana & PAD | Plant-based diets & blocked arteries ()
Impella heart pumps recalled | FDA's warning to iRhythm | Left bundle branch pacing | More from the week ()
Why health equity is important to cardiology | Cedars-Sinai AI tool offer personalized cardiac risk assessment ()
FDA clears temporary pacing guidewire for TAVR | More positive pulsed field ablation trial data ()
TAVR Highlights: New biomimetic valve linked to strong 1-year outcomes | Warfarin vs. DAPT, SAPT ()
Managing patients with SCAD | FDA says iRhythm committed multiple violations, failed to report deaths in time ()
Structural Heart Disease Highlights: A historic heart procedure | Medtronic's TPV | TVT 2023 ()
LBB pacing gaining momentum | Antithrombotic therapy after TAVR | Conformal Medical raises $35M ()
FDA announces recall of certain Impella heart pumps | An expert's take on SOLVE-CRT | Novo Nordisk close to $165M deal ()
News Alert: FDA announces recall of certain Impella heart pumps ()
Heart Failure Highlights: New dual cardiac device implanted for first time | FDA approves sotagliflozin | Much more ()
Fighting back against Medicare cuts to office-based services | New data on radiotherapy VT ablation | Heart Rhythm 2023 ()
New device used during TAVR for first time | Medicare cuts hit EP | Cardiologist salaries | More from the last week ()
May's Most Popular Stories: Cardiologists make history | Embracing AI | The first TAVR valve of its kind ()
New-look device used during TAVR for first time | Jury orders cardiologist to pay $2.6M | TAVR controversy ()
Economics Highlights: Compensation keeps climbing | Shockwave Medical acquisition rumors ()